Media Publications - Critical Path Institute

September 22, 2022

View Now: Workshop: Accelerating Medical Product Development in Kidney Transplantation Through a Public-private Partnership

C-Path’s Transplant Therapeutics Consortium (TTC), in collaboration with key opinion leaders from academic institutions,

August 12, 2022

C-Path’s Type 1 Diabetes Consortium (T1DC) is pleased to announce that “Consortium-based approach to receiving an EMA...

October 13, 2022-October 14, 2022

Early bird rates in effect until August 18! C-Path’s eCOA Consortium is co-sponsoring the DIA 2022 Digital Technology in Clini

August 17, 2022

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common myopathies affecting anywhere between 1:8,000 to 1:20,000

September 13, 2022-September 14, 2022

Since its launch in 2019, the Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) has established i

C-Path’s PRO Consortium announces that “Comparing patient global impression of severity and patient global impression of chang

C-Path’s PRO Consortium is pleased to announce that the Diary for Irritable Bowel Syndrome Symptoms–Constipation (DIBSS–C) i

July 19, 2022

C-Path’s eCOA Consortium is pleased to announce that “Administering Complex Cognitive Tests Remotely in The Cognitively-Impair

TUCSON, Ariz., July 14, 2022 — Critical Path Institute (C-Path) has named Amanda Klein, Pharm.D., as Executive Director for its